Surgical Resection Clinical Trials

3 recruiting

Surgical Resection Trials at a Glance

8 actively recruiting trials for surgical resection are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Delft, Groningen, and Guangzhou. Lead sponsors running surgical resection studies include SN BioScience, South Valley University, and Fudan University.

Browse surgical resection trials by phase

Treatments under study

About Surgical Resection Clinical Trials

Looking for clinical trials for Surgical Resection? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Surgical Resection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Surgical Resection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer

NSCLC Diagnosed by Histology or CytologyA Multidisciplinary Team Assessment Determined That the Patient Was a Suitable Candidate for Radical Surgical ResectionOverall Lung Function is Adequate for the Planned Lung Resection+1 more
Zhujiang Hospital46 enrolled1 locationNCT07534033
Recruiting
Phase 1Phase 2

SNB-101 for Treatment of Extensive Stage Small Cell Lung Cancer

Patient is Not Suitable for Complete Surgical Resection With a Cytologically or Histologically Confirmed Small Cell Lung Cancer(SCLC)
SN BioScience55 enrolled1 locationNCT07391813
Recruiting
Not Applicable

Bipolar Resection vs Enucleation of Prostate

Benign Prostatic Hyperplasia With Outflow ObstructionBenign Prostatic Hyperplasia (BPH) Requiring Surgical ResectionBenign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms+1 more
South Valley University100 enrolled1 locationNCT06983444
Recruiting

Meningioma and Embolism Thrombosis Risk & Investigation of Coagulation

Surgical ResectionMeningeomaThrombembolism
University Hospital Tuebingen100 enrolled1 locationNCT06709833
Recruiting

Primary Tumor Resection for M1a Stage Lung Cancer

Lung Cancer MetastaticSurgical Resection
Fudan University66 enrolled1 locationNCT06547710
Recruiting

Prediction Models for Complications After CRT in Esophageal Cancer

The Aim of This Project is to Develop and Validate NTCP-models for Complications After nCRT (and Surgical Resection)
University Medical Center Groningen2,000 enrolled8 locationsNCT06366828
Recruiting
Phase 2

OCEANiC: A Phase II, Open-label, Multi-centre Clinical Trial of Osimertinib With or Without Adjuvant Chemotherapy Guided by Tumour NGS Co-mutation Status and ctDNA Detection in Patients With Stage IIA-IIIA EGFR-Mutant Non Small Cell Lung Cancer Following Complete Surgical Resection

EGFR-Mutant Non Small Cell Lung Cancer Following Complete Surgical Resection
The University of Sydney100 enrolled11 locationsACTRN12623000552684
Recruiting
Phase 2

Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors

Surgical ResectionThe Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as anAdjuvant Therapy on the Clinical Outcome of Patients With Desmoid Tumors After
michal roll140 enrolled2 locationsNCT01898416